Navigation Links
Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
Date:8/24/2007

PALO ALTO, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that Mark A. Tarnopolsky, MD, PhD, FRCPC, professor at McMaster University in Hamilton, Ontario, Canada, presented a summary of findings demonstrating the positive effect of energy enhancing compounds for the potential treatment of neuromuscular diseases.

The findings were presented at the 10th International Congress on Amino Acids and Proteins (ICAAP) in Kallithea, Chalkidiki, Greece and is part of an ongoing collaborative program with Avicena to identify energy enhancing molecules as potential therapeutic agents for applications in neuromuscular diseases.

ABOUT AVICENA

Avicena Group, Inc. (OTC Bulletin Board: AVGO) is a Palo Alto, California based late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). The company is currently analyzing data from its Phase IIb/III trial in ALS. Near term, Avicena intends to initiate a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
2. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
6. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
7. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
8. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
9. Inspire Announces Presentations at Two European Scientific Conferences
10. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
11. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...,China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSky...")(Nasdaq: CSKI ),a,leadingfullyintegratedpharmace...erdrugsinthePeople,sRepublicofChina("PRC"),today,a...onalInstitutefor,theControlofPharmaceuticalandBiol...roducts:itsDiagnosticKitforHumanProstateSpecific,A...
(Date:11/25/2009)...M,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniumR...ologymarketintelligence,thenearly$3billionUSmarket...thoverthenextfiveyearsdespitetherecenteconomicslow...indsthatthismarketwillremainhighlydynamicoverthene...evicesinpreviouslyunderservedsegmentsofthetraumafi...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 1Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 2Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 4Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 1Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 4Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 1Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 2Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 3Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 4
...new tool that works within minutes, upon European ...TH, N.J., June 2 Schering-Plough,Corporation (NYS...dicinal,Products for Human Use (CHMP) of the Europ...al of sugammadex for routine reversal of the muscl...iate reversal of rocuronium,in adults, and for rou...
... results of the Spare the,Nephron (STN) study, a m...ing treatment protocol using CellCept(R) (mycophen...in combination with sirolimus,(SRL) is associated ...e,CellCept-based regimen in combination with calci...showed this improvement without increasing the,ris...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on Sugammadex 2European Union's CHMP Issues Positive Opinion on Sugammadex 3European Union's CHMP Issues Positive Opinion on Sugammadex 4European Union's CHMP Issues Positive Opinion on Sugammadex 5Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 2Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 3Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 4Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 5
(Date:11/25/2009)...orkingTogethertoShareRecordsSafely,ImproveCare ,...DepartmentofVeteransAffairs(VA)andKaiserPermanente...reandservicestoourNation,sheroes.VAandKaiserPerman...ealthrecord(EHR)informationusingtheNationwideHealt...ealthandHumanServices. ,, "Theabilitytosharecri...
(Date:11/25/2009)...ftistheLargestDonationEverMadeinSupportofFeedingAm...RNewswire-USNewswire/--FeedingAmerica,thenation,sl...illiondonationfromtheBankofAmericaCharitableFounda...ncomeAmericanswiththeSupplementalNutritionAssistan...hefundswillbeusedtohelpFeedingAmericafoodbanksimpr...
(Date:11/25/2009)... - Two signaling pathways essential to normal huma...al growth factor receptor (EGFR) pathways - intera...d metastasis, researchers from The University of T...v. 25 issue of Molecular Cell . , This newly ch...omponents known to correlate with invasive cancer ...
(Date:11/25/2009)...ES (Nov. 25, 2009) Melvin R. Kaplan, MD, FACP, a ...research institute that became Los Angeles Biomedi...er (LA BioMed), will be honored by the American Co...he care of patients. , At its April 22, 2010 mee...s will present Dr. Kaplan with the Ralph O. Claypo...
(Date:11/25/2009)...ov. 25, 2009 Physicians at UT Southwestern Medica...esigned to improve breathing in patients with uppe... them from breathing independently. , UT Southw...f only two sites in Texas and one of 25 in the cou...led the NeuRx Diaphragm Pacing System. , The dev...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
...b hoax calls are made by children as young as eigh...ried Delhi Police, battling a spate of prank calls... have done by seeking the help of psychiatrists. ...alling up the police control room. In the 13...
...Ranbaxy Laboratories and Aurobinda Pharma were amo...diagnostic companies applauded by UN Secretary Gen... access to HIV/AIDS treatment and prevention. ...United Nations Headquarters yesterday. Beside...
...s health authorities are in talks with doctors of ...recent employment rules that in effect make it vir... the National Health Service (NHS). As offic...udge has admitted the case filed in the high court...
...ay prevent many women from getting pregnant, but v...an restore fertility, a US researcher concluded.//...examined the value of psychological treatment for ...f 16 women was small and that a larger investigati...
... the wildly successful poster-child of a new gener... the cancer cell, can be dangerous to the heart.//...called tyrosine kinase inhibitors – could lead to ...sts led by Thomas Force, M.D., James C. Wilson Pro...
...are in charge of maintaining the water level in th...excreted out. When the kidneys get affected, it re...ch might lead to health complications and even chr...enal failure is not easy to detect and there are n...
Other Medicine News:Health News:Psychiatrist's Help Sought to Counsel Children Making Hoax Calls 2Health News:British Doctors Hold Talks to end Impasse of Indian doctors 2Health News:Stress Therapy can Restore Fertility: Study 2Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 2Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 3
...pinal Implant system. Material that has a modulus ... The result is an implant that meets the structura...ptimizing the fusion environment through an open, ...gn with 5 and 10 degrees of lordosis. Minimal inst...
...em provides anterior column support for single or ...rom T1 to L5. The system consists of one or more P... a desired height, accommodating various patient n...erial emulates the biomechanical properties of hum...
Rotafix Intervertebral Cage
Miniflex
Medicine Products: